{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:31:33Z","timestamp":1787967093582,"version":"build-2784847793"},"reference-count":26,"publisher":"BMJ","issue":"23","funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pulmonary Hypertension Association Foundation"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Phizer"},{"name":"Elikar Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Approximately 5%\u201310% of adults with congenital heart disease (CHD) develop pulmonary arterial hypertension (PAH), which affects life expectancy and quality of life. Arrhythmias are common among these patients, but their incidence and impact on outcome remains uncertain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All adult patients with PAH associated with CHD (PAH-CHD) seen in a tertiary centre between 2007 and 2015 were followed for new-onset atrial or ventricular arrhythmia. Clinical variables associated with arrhythmia and their relation to mortality were assessed using Cox analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 310 patients (mean age 34.9\u00b112.3 years, 36.8% male) were enrolled. The majority had Eisenmenger syndrome (58.4%), 15.2% had a prior defect repair and a third had Down syndrome. At baseline, 14.2% had a prior history of arrhythmia, mostly supraventricular arrhythmia (86.4%). During a median follow-up of 6.1 years, 64 patients developed at least one new arrhythmic episode (incidence 3.47% per year), mostly supraventricular tachycardia or atrial fibrillation (78.1% of patients). Arrhythmia was associated with symptoms in 75.0% of cases. The type of PAH-CHD, markers of disease severity and prior arrhythmia were associated with arrhythmia during follow-up. Arrhythmia was a strong predictor of death, even after adjusting for demographic and clinical variables (HR 3.41, 95%\u2009CI 2.10 to 5.53, p&lt;0.0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Arrhythmia is common in PAH-CHD and is associated with an adverse long-term outcome, even when managed in a specialist centre.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-312881","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T12:20:21Z","timestamp":1526646021000},"page":"1963-1969","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension"],"prefix":"10.1136","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-7231","authenticated-orcid":false,"given":"Maria","family":"Drakopoulou","sequence":"first","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"First Department of Cardiology, Hippokration Hospital, National and Kapodistrian Athens University, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Nashat","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Kempny","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Alonso-Gonzalez","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Swan","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Wort","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C","family":"Price","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"McCabe","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wong","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ernst","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"2025092015133556000_104.23.1963.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.07.198"},{"key":"2025092015133556000_104.23.1963.2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijcard.2016.05.046","article-title":"Adult congenital heart disease: A paradigm of epidemiological change","volume":"218","author":"Ntiloudi","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025092015133556000_104.23.1963.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.09.017"},{"key":"2025092015133556000_104.23.1963.4","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.098848"},{"key":"2025092015133556000_104.23.1963.5","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3283126954"},{"key":"2025092015133556000_104.23.1963.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.02.007"},{"key":"2025092015133556000_104.23.1963.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl116"},{"key":"2025092015133556000_104.23.1963.8","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305690"},{"key":"2025092015133556000_104.23.1963.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.883876"},{"key":"2025092015133556000_104.23.1963.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017202"},{"key":"2025092015133556000_104.23.1963.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr461"},{"key":"2025092015133556000_104.23.1963.12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592410"},{"key":"2025092015133556000_104.23.1963.13","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00003309"},{"key":"2025092015133556000_104.23.1963.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.024"},{"key":"2025092015133556000_104.23.1963.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht437"},{"key":"2025092015133556000_104.23.1963.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.09.002"},{"key":"2025092015133556000_104.23.1963.17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijcard.2017.01.111","article-title":"Early mortality and concomitant procedures related to Fontan conversion: Quantitative analysis","volume":"236","author":"Brida","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025092015133556000_104.23.1963.18","first-page":"67","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"2016","author":"Galie","year":"2015","journal-title":"Eur Heart J"},{"key":"2025092015133556000_104.23.1963.19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijcard.2014.11.100","article-title":"Physiological differences between various types of Eisenmenger syndrome and relation to outcome","volume":"179","author":"Moceri","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025092015133556000_104.23.1963.20","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/ehjci\/jew277","article-title":"Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain","volume":"18","author":"Moceri","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025092015133556000_104.23.1963.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.07.227"},{"key":"2025092015133556000_104.23.1963.22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2015.02.031","article-title":"Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry","volume":"184","author":"Alonso-Gonzalez","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025092015133556000_104.23.1963.23","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309835"},{"key":"2025092015133556000_104.23.1963.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw161"},{"key":"2025092015133556000_104.23.1963.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309302"},{"key":"2025092015133556000_104.23.1963.26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acvd.2017.01.006","article-title":"Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study","volume":"110","author":"Hascoet","year":"2017","journal-title":"Arch Cardiovasc Dis"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-312881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T22:13:47Z","timestamp":1758406427000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-312881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":26,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2018,11,14]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1136\/heartjnl-2017-312881"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-312881","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}